Back to Newsroom

Catalyst Pharmaceuticals Announces Second Quarter 2017 Financial Results and Provides Corporate Update

CORAL GABLES, Fla., Aug. 09, 2017 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating neuromuscular and neurological diseases, today reported financial results for the second quarter ended June 30, 2017 and provided a corporate update.